Book contents
- Mass Tort Deals
- Mass Tort Deals
- Copyright page
- Dedication
- Contents
- Figures
- Tables
- Acknowledgments
- Introduction
- 1 When Mass Torts Meet Multidistrict Litigation
- 2 Quid Pro Quo Arrangements?
- 3 The Rise of Repeat Players
- 4 Judges as Bulwarks and Nudgers
- 5 When Multidistrict Litigation Settles into “Alternative Dispute Resolution”
- 6 Reforming Multidistrict Litigation
- Conclusion
- Appendix
- Index
Conclusion
Published online by Cambridge University Press: 16 May 2019
- Mass Tort Deals
- Mass Tort Deals
- Copyright page
- Dedication
- Contents
- Figures
- Tables
- Acknowledgments
- Introduction
- 1 When Mass Torts Meet Multidistrict Litigation
- 2 Quid Pro Quo Arrangements?
- 3 The Rise of Repeat Players
- 4 Judges as Bulwarks and Nudgers
- 5 When Multidistrict Litigation Settles into “Alternative Dispute Resolution”
- 6 Reforming Multidistrict Litigation
- Conclusion
- Appendix
- Index
Summary
Brooke Melton (GM), Michelle Pfeleger (Yasmin/Yaz), Linda Isner (Vioxx), Gene Weeks (Vioxx), Trudy Thomas (Kugel Mesh), Erika Langhart (NuvaRing), and David Foscue (Zimmer) are but a handful of the faces behind multidistrict litigation statistics. Stories like theirs lurk within many of the more than 312,500 actions included in this book’s dataset. In each case, it would be easy to pin blame on the lawyers, the FDA, the company, or the doctors. But targeting only one paints an incomplete picture and misses the point: there are problems with each that affect, reflect, and amplify failings elsewhere.
- Type
- Chapter
- Information
- Mass Tort DealsBackroom Bargaining in Multidistrict Litigation, pp. 215 - 222Publisher: Cambridge University PressPrint publication year: 2019